352770 — Clinomics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Market Cap
KR₩62bn
Enterprise Value
KR₩74bn
Revenue
KR₩11bn

Annual balance sheet for Clinomics, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	17,072	29,883	43,847	17,649	11,996
Net Total Accounts Receivable
Net Total Receivables	1,596	1,902	28,128	30,691	1,914
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	20,397	33,225	74,425	52,095	18,199
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	6,211	9,467	19,957	28,522	28,284
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	26,936	43,760	102,587	97,104	74,484
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	2,259	2,533	39,222	36,681	24,282
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	21,886	3,841	43,974	44,166	35,852
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	5,050	39,920	58,614	52,938	38,632
Total Liabilities & Shareholders' Equity	26,936	43,760	102,587	97,104	74,484
Total Common Shares Outstanding
Total Preferred Shares Outstanding